ScoreWhy is Sansure Biotech, Inc. ?
1
Poor long term growth as Net Sales has grown by an annual rate of -23.58% and Operating profit at -52.58% over the last 5 years
2
The company has declared Negative results for the last 10 consecutive quarters
- NET PROFIT(9M) At CNY 207.18 MM has Grown at -38.85%
- DEBT-EQUITY RATIO (HY) Highest at -49.37 %
- INTEREST(Q) Highest at CNY 6.1 MM
3
With ROE of 2.60%, it has a very attractive valuation with a 1.59 Price to Book Value
- Over the past year, while the stock has generated a return of -17.20%, its profits have fallen by -49.9%
- At the current price, the company has a high dividend yield of 4
4
Below par performance in long term as well as near term
- Along with generating -17.20% returns in the last 1 year, the stock has also underperformed China Shanghai Composite in the last 3 years, 1 year and 3 months
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Sansure Biotech, Inc. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Sansure Biotech, Inc. for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Sansure Biotech, Inc.
-100.0%
0.24
37.49%
China Shanghai Composite
15.19%
1.01
14.58%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
-23.58%
EBIT Growth (5y)
-52.58%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.50
Sales to Capital Employed (avg)
0.29
Tax Ratio
11.45%
Dividend Payout Ratio
108.99%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
87.81%
ROE (avg)
18.63%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
61
Industry P/E
Price to Book Value
1.59
EV to EBIT
58.00
EV to EBITDA
24.67
EV to Capital Employed
2.03
EV to Sales
5.31
PEG Ratio
NA
Dividend Yield
4.01%
ROCE (Latest)
3.49%
ROE (Latest)
2.60%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bullish
No Trend
OBV
No Trend
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend8What is working for the Company
RAW MATERIAL COST(Y)
Fallen by -4.55% (YoY
NET SALES(Q)
Highest at CNY 472.65 MM
PRE-TAX PROFIT(Q)
Highest at CNY 112 MM
NET PROFIT(Q)
Highest at CNY 90.78 MM
EPS(Q)
Highest at CNY 0.16
-15What is not working for the Company
NET PROFIT(9M)
At CNY 207.18 MM has Grown at -38.85%
DEBT-EQUITY RATIO
(HY)
Highest at -49.37 %
INTEREST(Q)
Highest at CNY 6.1 MM
Here's what is working for Sansure Biotech, Inc.
Net Sales
Highest at CNY 472.65 MM
in the last five periodsMOJO Watch
Near term sales trend is positive
Net Sales (CNY MM)
Net Sales
At CNY 472.65 MM has Grown at 21.63%
Year on Year (YoY)MOJO Watch
Near term sales trend is positive
Net Sales (CNY MM)
Pre-Tax Profit
Highest at CNY 112 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (CNY MM)
Net Profit
Highest at CNY 90.78 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is positive
Net Profit (CNY MM)
EPS
Highest at CNY 0.16
in the last five periodsMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (CNY)
Raw Material Cost
Fallen by -4.55% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Sansure Biotech, Inc.
Interest
At CNY 6.1 MM has Grown at 283.2%
period on period (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (CNY MM)
Debt-Equity Ratio
Highest at -49.37 % and Grown
In each half year in the last five Semi-Annual periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio
Interest
Highest at CNY 6.1 MM
in the last five periods and Increased by 283.2% (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (CNY MM)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
